Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression

This publication has 28 references indexed in Scilit:

• Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
  Nature Communications, 2016
• Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease
  Diabetes, 2015
• Prostate cancer detection: The impact of obesity on Asian men
  Urologic Oncology: Seminars and Original Investigations, 2015
• Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies
  Oncology Letters, 2014
• American Society of Clinical Oncology Position Statement on Obesity and Cancer
  Journal of Clinical Oncology, 2014
• Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
  The Lancet Oncology, 2008
• Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle‐aged men
  Cancer, 2007
• Obesity and the risk of prostate cancer
  The Prostate, 2004
• Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy
  Journal of Clinical Oncology, 2004
• Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
  New England Journal of Medicine, 2003